GIP Produkte
(Gastric Inhibitory Polypeptide (GIP))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte GIP Kategorien
GIP Antikörper
High quality antibodies with extensive validation data.
GIP ELISA Kits
Reliable ELISA kits for a wide range of species.
GIP Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene GIP Antikörper
- (3)
- (3)
- (2)
Empfohlene GIP ELISA Kits
- (3)
- (1)
- (1)
- (1)
Empfohlene GIP Proteine
- (3)
- (3)
- (2)
Neueste Publikationen zu unseren GIP Produkten
: "The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats." in: Obesity surgery, Vol. 30, Issue 2, pp. 697-706, (2020) (PubMed).: "Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients." in: Diabetes research and clinical practice, Vol. 158, pp. 107928, (2020) (PubMed).
: "The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats." in: Obesity surgery, Vol. 28, Issue 3, pp. 748-759, (2018) (PubMed).
: "Regenerative Potential of Spermatogonial Stem Cells, Endothelial Progenitor Cells, and Epithelial Progenitor Cells of C57Bl/6 Male Mice with Metabolic Disorders." in: Bulletin of experimental biology and medicine, Vol. 163, Issue 2, pp. 239-244, (2018) (PubMed).
: "Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1���cells in vitro by down-regulating the PCSK1/3." in: Cancer letters, Vol. 431, pp. 190-200, (2018) (PubMed).
: "Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model." in: Obesity surgery, Vol. 28, Issue 5, pp. 1313-1320, (2018) (PubMed).
: "A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice." in: Journal of atherosclerosis and thrombosis, Vol. 23, Issue 4, pp. 441-54, (2017) (PubMed).
: "Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury." in: Experimental neurology, Vol. 288, pp. 176-186, (2017) (PubMed).
: "The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlying signaling mechanisms in a rat model of diabetes mellitus." in: Scientific reports, Vol. 6, pp. 34284, (2016) (PubMed).
: "Specificity and promiscuity in human glutaminase interacting protein recognition: insight from the binding of the internal and C-terminal motif." in: Biochemistry, Vol. 51, Issue 35, pp. 6950-60, (2012) (PubMed).
Synonyme und alternative Namen zu GIP
gastric inhibitory polypeptide (GIP), gastric inhibitory polypeptide (gip), gastric inhibitory polypeptide (Gip), gastric inhibitory polypeptide L homeolog (gip.L), GIP, Gludins, RATGLUDINS, xgipBezeichner auf Proteinebene für GIP
- glucose-dependent insulinotropic polypeptide
- gastric inhibitory polypeptide
- incretin hormone
- Glucose-dependent insulinotropic peptide